clinical studylínchuáng yánjiū临床研究shows / indicatesxiǎnshì显示new drugxīn yào新药zorevunersen (epilepsy drug)Zuǒléifúnàsēn佐雷伏纳森to cause / makeshǐ使Dravet syndrome (severe epilepsy)Délāwéi Zōnghézhēng德拉韦综合征children with the diseasehuàn ér患儿epilepsy / seizuresdiānxián癫痫attacks / episodesfāzuò发作at mostzuì duō最多to reducejiǎnshǎo减少90 percentjiǔ chéng九成。
clinical study
línchuáng yánjiū
临床研究
shows / indicates
xiǎnshì
显示
new drug
xīn yào
新药
zorevunersen (epilepsy drug)
Zuǒléifúnàsēn
佐雷伏纳森
to cause / make
shǐ
使
Dravet syndrome (severe epilepsy)
Délāwéi Zōnghézhēng
德拉韦综合征
children with the disease
huàn ér
患儿
epilepsy / seizures
diānxián
癫痫
attacks / episodes
fāzuò
发作
at most
zuì duō
最多
to reduce
jiǎnshǎo
减少
90 percent
jiǔ chéng
九成
published
fābiǎo
发表
in
yú
于
New England Journal of Medicine
Xīn Yīnggélán Yīxué Zázhì
新英格兰医学杂志
(particle)
de
的
study
yánjiū
研究
confirmed / proved
zhèngshí
证实
new type / novel
xīnxíng
新型
drug
yàowù
药物
zorevunersen
Zuǒléifúnàsēn
佐雷伏纳森
can
kě
可
to cause / make
shǐ
使
Dravet syndrome
Délāwéi Zōnghézhēng
德拉韦综合征
children with the disease
huàn ér
患儿
per month
měi yuè
每月
epilepsy / seizures
diānxián
癫痫
attacks
fāzuò
发作
number of times
cìshù
次数
to reduce
jiǎnshǎo
减少
at most
zuì duō
最多
reaching / up to
dá
达
90 percent
jiǔ chéng
九成
the study
yánjiū
研究
also
hái
还
found
fāxiàn
发现
this / the mentioned
gāi
该
drug
yàowù
药物
during
zài
在
three-year
sān nián
三年
period / cycle
zhōuqī
周期
within
nèi
内
improved
gǎishàn
改善
(completion particle)
le
了
children with the disease
huàn ér
患儿
(particle)
de
的
cognitive function
rènzhī gōngnéng
认知功能
and
yǔ
与
quality of life
shēnghuó zhìliàng
生活质量
research team
yánjiū tuánduì
研究团队
already / has
yǐ
已
based on this
jù cǐ
据此
launched / initiated
qǐdòng
启动
larger-scale
guīmó gèng dà
规模更大
(particle)
de
的
phase 3
sān qī
三期
clinical trial
línchuáng shìyàn
临床试验